Member Info for CHELSEA7

Inanaco if anything I was trying to get an idea of how these deals are structured without adding variables to the equation, there are so many, and both your post and Rucks have helped make it clearer for me. I was rather hoping any deals would be structured as to how you explained, so thanks.

Talking about variables and keeping them as simple as possible do you have any thoughts as to timelines where one of our collaborators can get indications as to wanting to use Avidamab for whatever projects they are using it for?? I would guess there are far too many variables to answer that one?

Inanaco, will never understand how a decent question and answer which would have led into an interesting conversation can turn into a battle. That being the case can you explain how such deals are normally structured, IF there is a norm?

Thanks Ruck for replying.

Buys 32k........3 trades

Sells 6k........1 trade

2 trades on NEX

18/12/2019 13:24 8,988 5.43
18/12/2019 11:42 5,000 5.43

OK, so you chose not to read my post just after....................

""Thanks Ruck, I am working on the basis that licensing fees are paid annually, would that be correct? and if so have you calculated that into the equation??""".....................never mind!!

You posted also..................that is stage payment

not licence

SCIB2 has a license but no upfront or stage payment only Royalties

Well I was talking specifically about Avidamab, and asking specifically I am right in thinking it would be an annual recurring licensing deal. Genuine question, for many years in my business my clients paid an annual fee for the companies services, What makes that a stage payment?? I really have no idea how licensing deals are structured in this Industry.

Inanaco...........calculate £5m ? up front ?

divide it by the share base.

I would have thought that if we are talking about a recurring annual licencing fee, that figure would be more??

How would you calculate it Inanaco??

Bermuda, this should open correctly.............

http://commercial.cancerresearchuk.org/first-human-trial-new-lung-cancer-immunotherapy

Inanaco................""(..impossible to quantify ..

"""you have no idea of the cash outflows next year "")

With all due respect we are both very aware of that ""the variables"" but it is a very relevant question, so just to make it easier presume the overheads remain the same, or we could even from past experience take a very good calculated guess as to the cost of manufacture of MOD2 or any other vaccines needed in smaller quantities for development purposes. Which is exactly why we brought in a Head of Manufacturing to seriously cut the costs of manufacturing smaller quantities.

Thanks Ruck, I am working on the basis that licensing fees are paid annually, would that be correct? and if so have you calculated that into the equation??

Inanaco, I am fully aware it was a very difficult question to answer, which is why I asked on the basis of keeping variables as simple as possible, just to get a very rough idea of what to hope for. Indeed it really would help endorse the other platforms and of course being non-exclusive deals the potential to increase revenue would be huge.

Ruck, thanks for keeping it as simple as I tried to make it, we know there could be any number of variables and appreciate your reply.

Over on NEX, just for a few, so indicative spread is 10%, actual spread 5.23/5.43..............about 4%

They are certainly in no rush to tick up on the bid, lol.

I think a bit of price conditioning going on here, seen it more than a few times in recent months when larger trades are to be accomadated................

Up to 120k nw at 5.23.................still creeping up

But 121k - 160k at just 5.09!!!

Nor would PD (ME)!!

Both feet firmly on the floor Ruck, and although significantly down any of those price points are very possible with the pipelines we have going. Relly asm delighted with that China collaboration, 2 such deals going in 2 continents for a pretty new platform augurs well.

Tell me Ruck if you can, and this is just one scenario if we were in a position to receive £5m in licence fees for Avidamab by H2 2020 what kind of valuation would that make on our current SP presuming no other funding was necessary and timelines/revised timelines for SCIB1 are met.

Still not sure how I view the situation with SCIB1, I just had a feeling for this weeks news before year end to set us up for 2020 and I have an even stronger feeling that a major item of news in the early part of the New Year will be that we have re-submitted the IND to the FDA, and that being the case we could be forgiven for thinking Approval could take just 28 days thereafter. That IMHO would be seen as a very positive step, one that will be looked favourably upon by LTH with MOD1 meeting its timeline and further good news with all our platforms.

I still stand by 50p as a distinct possibility, and just wonder how much/little very good news it would take to see us past 10p and into the teens??

Up to 110k now at 5.2226

Bid still creeping up.............up to 80k at 5.2226 and 180k at 5.21

Wheres that tick up??

For 19k

Taking 180k at 5,21

SP unchanged 5/5.50

Been a fair amount of time since I last woke up automatically before 7.00, and not expecting an RNS, nor that daily feeling of disappointment that there isn"t one.

Yeah happy what we have got the last two days, and feel just that little boost in confidence that I was hoping for to take us into 2020. The general consensus of opinion here was good and for me yesterdays RNS really added to the one we got on Monday.

Even without Vulpes purchase the volume was just short of 500k with sells being in single figures.

Some interesting movements on the bid yesterday, enough for me to think we could have a very interesting day and end of week here this week. and whilst i make my 3rd cup of tea, hoping to see that bid tick up after a very decent buy..............a sell could do it too, as after each one of three yesterday afternoon the bid rose as did the volume the MMs would take.

So to a good day and good to see a few familiar faces posting again yesterday.

Crackin, that is not FACT or FICTION but selective date picking.

Last Thursday the 12th December the share was trading at 4.80/5, a few sells were taken at 4.80 and 1 Buy full ask 5p was paid.

So whilst the 3m trade had no immediate effect on the bid or ask,, the end result after seeing many sells is 10% up. You can word it how you like, choose a date to suit you best but those are FACTS, and not just seen in the aftermath of one trade. Dependant on any trades or not we will probably see a nice tick up on the bid too.

So not sure what big point you are trying to make, but the share is up, that is a fact. And regardless of anything else you accused me of posting false information, it definately wasn"t a buy, when after putting ?? against it Monday i just commented Tuesday morning it was looking better for it to be a buy. I hope from now on in, you won"t be posting false information, and as I did put a question mark against it as it needed if we could further confirmation. I think the Holding RNS did that, otherwise your FICTION could easily have been mistaken for a FACT!!!

Jeez, it"s cold this morning, lol, back to zzzzzzzzzzzzzz

So simply just 5 days on from there the ask alone was up to Full Ask Paid 5.50 a rise of exactly 10% and the bid having risen from 4.80 to 5.2155 is just under 9% up.

On our way to 50p Ruck, via 10p, 15p,25p, lets hope this works out, loading bases. GN

I wonder what made you purchase shares here, Aimbig, posted you secured more recently as you couldn"t resist, to gain trust and now reverting to type by saying as many negative things as you can think of, despite no bad news being issued and increasing by the post statements which are not facts, presented as such, and as today just another misleading fact, proven to be so.. This has been the pattern over at least six IDs. over some time.

Never mind our feet are grounded,..........again the share has increased in a few working days significantle enough 12% on the Ask and 9% on the bid, you say............ "" """They do deals without any financial consideration. They have II's acquiring shares off market so no SP increase ""............untrue, misleading

Further............... """ and they are incapable of generating income."""

I guess that is one of your facts too!!!